(NASDAQ: TBIO) Telesis Bio's forecast annual revenue growth rate of 27.86% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.34%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Telesis Bio's revenue in 2024 is $27,509,000.On average, 1 Wall Street analysts forecast TBIO's revenue for 2024 to be $1,068,666,582, with the lowest TBIO revenue forecast at $1,068,666,582, and the highest TBIO revenue forecast at $1,068,666,582.
In 2025, TBIO is forecast to generate $1,399,802,706 in revenue, with the lowest revenue forecast at $1,399,802,706 and the highest revenue forecast at $1,399,802,706.